Posts tagged ONCS


Here’s What This Bull Sees Next for OncoSec Medical Inc (ONCS) on Back of Phase II Combination Trial Success

H.C. Wainwright’s Ram Selvaraju anticipates ONCS could apply with Phase IIb data for Breakthrough Therapy designation.

Read more

OncoSec Medical Inc (ONCS) Hits New Record Highs; Here’s Why

It’s a very rewarding trading day for investors in OncoSec Medical Inc (NASDAQ:ONCS) with shares …

Read more

Maxim Weighs in on OncoSec Medical Inc (ONCS) Ahead of Immune Data Presentation

OncoSec Medical Inc (NASDAQ:ONCS) shares are rising almost 8% ahead of the biotech firm’s immune …

Read more

Stock Update (NASDAQ:ONCS): OncoSec Medical Inc Announces Fourth Quarter and Year End Results for Fiscal Year 2016

OncoSec Medical Inc (NASDAQ:ONCS) announced financial results for the fourth quarter and fiscal year ended July …

Read more

Company Update (NASDAQ:ONCS): OncoSec Medical Inc Appoints Sharron Gargosky, PhD, to Chief Clinical and Regulatory Officer

OncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced Sharron Gargosky, PhD, …

Read more

Company Update (NASDAQ:ONCS): OncoSec Medical Inc Presents Preliminary Findings from Head and Neck Phase II Clinical Trial at EUROGIN 2016 Conference

OncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today presented preliminary findings from …

Read more

Stock Update (NASDAQ:ONCS): OncoSec Medical Inc Closes $10 Million At-The-Market Registered Direct Offering

OncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that it has …

Read more

Stock Update (NASDAQ:ONCS): OncoSec Medical Inc Announces Second Quarter and YTD Results for Fiscal Year 2016 and Calendar 2016 Milestones

OncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced key corporate objectives …

Read more

Stock Update (NASDAQ:ONCS): OncoSec Medical Inc Opens New Headquarters and Research Facility in San Diego

OncoSec Medical Inc (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced the Company …

Read more

Looking Ahead of Wall Street: GW Pharmaceuticals PLC- ADR (GWPH), Costco Wholesale Corporation (COST), OncoSec Medical Inc (ONCS), and AutoZone, Inc. (AZO)

Here’s what to watch for this week from GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Costco Wholesale Corporation (NASDAQ:COST), OncoSec …

Read more